FDA Cracks Down on Knockoff Mounjaro: Protecting Obesity Treatment Safety
26 Dec 2024
FDA Says Knockoff Versions of Lilly Obesity Drug Must Come Off the Market In a significant move to protect consumers and ensure the safety of medical treatments, the U.S. Food and Drug Administration (FDA) has taken action against unauthorized, knockoff versions of the popular obesity drug, Mounjaro, manufactured by Eli...
Read More
